Post Content
September 9, 2025
- Judge Advances Particle Health’s Antitrust Lawsuit Against Epic
- Takeda Is Waking Up the Narcolepsy Market With First-in-Class Drug, But Alkermes Is on Its Heels
- WeightWatchers Introduces New Menopause Program
- Summit Lung Cancer Drug Falls Short on Key Survival Goal in Global Study, Putting FDA Approval in Doubt
Headlines
